SCHEMBL30788956

SCHEMBL30788956

CS(=O)(=O)OCC(C1CCC1)n1nccn1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21244739 0.71 ALDH1A1 (0.34) —
SCHEMBL9636678 0.71 ALDH1A1 (0.34) —
SCHEMBL7804617 0.63 ALDH1A1 (0.37) —
SCHEMBL4284111 0.62 ALDH1A1 (0.31) —
SCHEMBL30643428 0.62 ALDH1A1 (0.37) —
SCHEMBL13661456 0.61 ALDH1A1 (0.33) —
SCHEMBL2349502 0.60 ALDH1A1 (0.41) —
SCHEMBL11854679 0.60 MEN1 (0.48) —
SCHEMBL9413690 0.60 MEN1 (0.40) —
SCHEMBL21988516 0.59 CYP19A1 (0.32) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4565228-A2 COMPOSITIONS AND METHODS FOR INDUCING FERROPTOSIS Kojin Therapeutics, Inc. (US) 2025-06-11 — — EP disclosed
WO-2024030960-A2 COMPOSITIONS AND METHODS FOR INDUCING FERROPTOSIS Kojin Therapeutics, Inc. (US) 2024-02-08 — — WO disclosed
Send feedback